Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

Next-generation T-cell therapies will likely continue to utilize T-cell receptors (TCRs) and chimeric antigen receptors (CARs) because each receptor type has advantages. TCRs often possess exceptional properties even when tested unmodified from patients’ T cells. CARs are generally less sensitive, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xueyin, Sandberg, Mark L., Martin, Aaron D., Negri, Kathleen R., Gabrelow, Grant B., Nampe, Daniel P., Wu, Ming-Lun, McElvain, Michele E., Toledo Warshaviak, Dora, Lee, Wen-Hua, Oh, Julyun, Daris, Mark E., Chai, Falene, Yao, Christine, Furney, James, Pigott, Craig, Kamb, Alexander, Xu, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Basic Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415731/
https://www.ncbi.nlm.nih.gov/pubmed/34432728
http://dx.doi.org/10.1097/CJI.0000000000000386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415731/
https://www.ncbi.nlm.nih.gov/pubmed/34432728
http://dx.doi.org/10.1097/CJI.0000000000000386

Ejemplares similares